JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Repligen
RGEN
$7.96B
| $3.46M | ﹤0.01% |
+83,747
| New | +$3.07M |
|
|
ATYR
2477
aTyr Pharma
ATYR
$47.6M
| $3.45M | ﹤0.01% |
+13,304
| New | +$4.13M |
|
2478
CALL
D.R. Horton
DHI
$40B
| $3.44M | ﹤0.01% |
125,800
+122,100
| +3,300% | +$3.28M |
|
|
HVB
2479
DELISTED
HUDSON VY HLDG CORP
HVB
| $3.44M | ﹤0.01% |
121,992
+3,000
| +3% | +$78.1K |
|
|
QTS
2480
DELISTED
QTS REALTY TRUST, INC.
QTS
| $3.43M | ﹤0.01% |
94,200
+88,329
| +1,504% | +$3.27M |
|
|
SWN
2481
PUT
DELISTED
Southwestern Energy Company
SWN
| $3.43M | ﹤0.01% |
150,900
+150,000
| +16,667% | +$3.85M |
|
|
VSLR
2482
DELISTED
VIVINT SOLAR, INC.
VSLR
| $3.43M | ﹤0.01% |
281,650
-75,899
| -21% | -$1.04M |
|
|
CHTR
2483
PUT
DELISTED
CHARTER COMMUNICATIONS CL-A
CHTR
| $3.42M | ﹤0.01% |
+20,000
| New | +$3.42M |
|
2484
PUT
Danaher
DHR
$137B
| $3.42M | ﹤0.01% |
59,513
-37,196
| -38% | -$2.13M |
|
2485
PUT
Bristol-Myers Squibb
BMY
$133B
| $3.41M | ﹤0.01% |
51,300
| – | – |
|
|
IMDZ
2486
DELISTED
Immune Design Corp.
IMDZ
| $3.41M | ﹤0.01% |
165,084
-38,466
| -19% | -$909K |
|
|
SCNB
2487
DELISTED
Suffolk Bancorp
SCNB
| $3.39M | ﹤0.01% |
132,219
+6,275
| +5% | +$154K |
|
2488
Maximus
MMS
$3.17B
| $3.39M | ﹤0.01% |
51,574
+487
| +1% | +$31.9K |
|
2489
CALL
Cogent Communications
CCOI
$676M
| $3.38M | ﹤0.01% |
+99,900
| New | +$3.35M |
|
|
ANDV
2490
PUT
DELISTED
Andeavor
ANDV
| $3.38M | ﹤0.01% |
40,000
-16,040
| -29% | -$1.39M |
|
|
CHTR
2491
CALL
DELISTED
CHARTER COMMUNICATIONS CL-A
CHTR
| $3.37M | ﹤0.01% |
+19,700
| New | +$3.37M |
|
|
TBI
2492
Trueblue
TBI
$215M
| $3.36M | ﹤0.01% |
112,386
-180,838
| -62% | -$5.09M |
|
|
CPL
2493
DELISTED
CPFL Energia S.A.
CPL
| $3.36M | ﹤0.01% |
281,001
-637
| -0.2% | -$7.99K |
|
2494
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.09B
| $3.35M | ﹤0.01% |
67,575
+21,125
| +45% | +$1.05M |
|
2495
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $3.35M | ﹤0.01% |
31,657
+19,046
| +151% | +$2.01M |
|
|
ITC
2496
DELISTED
ITC HOLDINGS CORP
ITC
| $3.35M | ﹤0.01% |
103,976
+11,005
| +12% | +$384K |
|
|
JBTM
2497
JBT Marel
JBTM
$7.21B
| $3.34M | ﹤0.01% |
88,921
-766
| -0.9% | -$28.2K |
|
|
BRG
2498
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $3.33M | ﹤0.01% |
+263,200
| New | +$3.54M |
|
|
RP
2499
DELISTED
RealPage, Inc.
RP
| $3.33M | ﹤0.01% |
174,623
+218
| +0.1% | +$4.22K |
|
2500
Bloomin' Brands
BLMN
$741M
| $3.32M | ﹤0.01% |
155,487
-1,003,800
| -87% | -$22.6M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.